HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Damien Sternberg Selected Research

Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)

11/2018A204E mutation in Nav1.4 DIS3 exerts gain- and loss-of-function effects that lead to periodic paralysis combining hyper- with hypo-kalaemic signs.
1/2018Substitutions of the S4DIV R2 residue (R1451) in NaV1.4 lead to complex forms of paramyotonia congenita and periodic paralyses.
4/2010Homozygosity for dominant mutations increases severity of muscle channelopathies.
3/2009Glucocorticoids may trigger attacks in several types of periodic paralysis.
2/2008Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene.
5/2007Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Damien Sternberg Research Topics

Disease

9Myotonia
01/2020 - 11/2004
8Channelopathies
10/2015 - 05/2007
7Paralysis (Palsy)
01/2020 - 11/2004
6Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)
11/2018 - 05/2007
4Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
01/2022 - 09/2014
4Myotonic Disorders (Paramyotonia Congenita)
01/2019 - 02/2004
3Myotonia Congenita (Thomsen Disease)
10/2015 - 02/2008
2Atrophy
01/2020 - 09/2014
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2022
1Brody myopathy
01/2020
1Muscular Diseases (Myopathy)
01/2020
1Potassium aggravated myotonia
01/2019
1Hyperkalemic Periodic Paralysis
11/2018
1Congenital myasthenic syndrome with episodic apnea
01/2016
1Cognitive Dysfunction
01/2016
1Neuromuscular Junction Diseases
09/2014
1Muscle Weakness
09/2014
1Distal Myopathies (Distal Muscular Dystrophy)
09/2014
1Lactic Acidosis
11/2013
1Mitochondrial encephalopathy
11/2013
1Stroke (Strokes)
11/2013
1MELAS Syndrome (Syndrome, MELAS)
11/2013
1Gastroesophageal Reflux (GERD)
09/2013
1Arthrogryposis
04/2013
1Hyperglycemia
03/2009
1Insulin Resistance
03/2009
1Muscle Hypotonia (Hypotonia)
03/2009
1Hypokalemia
03/2009
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2007
1Myotonic Dystrophy (Dystrophia Myotonica)
05/2007
1Deafness (Deaf Mutism)
12/2002
1Sensorineural Hearing Loss
12/2002
1Nonsyndromic Deafness
12/2002
1Mitochondrial Diseases (Mitochondrial Disease)
11/2002
1Sclerosing Cholangitis
08/2002

Drug/Important Bio-Agent (IBA)

5SodiumIBA
02/2008 - 11/2004
4Voltage-Gated Sodium ChannelsIBA
01/2019 - 02/2008
4Sodium Channels (Sodium Channel)IBA
09/2013 - 02/2004
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2015
3Calcium Channels (Calcium Channel)IBA
11/2018 - 11/2004
3Chloride Channels (Chloride Channel)IBA
10/2015 - 02/2008
3Mitochondrial DNA (mtDNA)IBA
11/2013 - 12/2002
3ChloridesIBA
11/2007 - 11/2004
2CalciumIBA
01/2020 - 05/2007
2Carbamazepine (Tegretol)FDA LinkGeneric
01/2020 - 09/2013
2GlucocorticoidsIBA
01/2018 - 03/2009
2Ion Channels (Ion Channel)IBA
10/2015 - 09/2006
2PotassiumIBA
03/2009 - 02/2008
1Albuterol (Salbutamol)FDA LinkGeneric
01/2022
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2022
1LaminsIBA
01/2022
1Synaptotagmin IIIBA
12/2020
1Lysine (L-Lysine)FDA Link
01/2020
1Arginine (L-Arginine)FDA Link
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1Sodium Channel BlockersIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Mexiletine (Mexitil)FDA LinkGeneric
01/2019
1EnzymesIBA
08/2017
1Cholinergic Agents (Cholinergics)IBA
01/2016
1choline transporterIBA
01/2016
1AgrinIBA
09/2014
1Proteoglycans (Proteoglycan)IBA
09/2014
1Acetazolamide (Diamox)FDA LinkGeneric
11/2013
1EndopeptidasesIBA
04/2013
1Islet Amyloid PolypeptideIBA
03/2009
1Adenosine Triphosphatases (ATPase)IBA
03/2009
1Insulin (Novolin)FDA Link
03/2009
1Ile Transfer RNAIBA
12/2007
1Transfer RNA (tRNA)IBA
12/2007
1Ser Transfer RNAIBA
12/2002
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
08/2002

Therapy/Procedure

1Therapeutics
11/2002